Rifabutin-containing Triple Therapy versus Bismuth Quadruple Therapy for Helicobacter pylori Rescue Treatment: A Multicenter, Randomized Controlled Trial.

Jinnan ChenYixian GuoYu HuangZhaohui DingJing WangLing XiaoPing XuYaohua HanHong Lu

Published in: The Journal of infectious diseases (2023)

The rifabutin triple therapy is an alternative to classical bismuth quadruple therapy for the rescue treatment of H. pylori with lower side effects and higher compliance.

Keyphrases

helicobacter pylori
helicobacter pylori infection
randomized controlled trial
stem cells
study protocol
clinical trial
combination therapy
cross sectional
visible light